HLB Therapeutics Co.,Ltd. (115450.KQ)

KRW 10680.0

(-2.11%)

Inventory Summary of HLB Therapeutics Co.,Ltd.

  • HLB Therapeutics Co.,Ltd.'s latest annual inventory in 2023 was 5.33 Billion KRW , down -17.34% from previous year.
  • HLB Therapeutics Co.,Ltd.'s latest quarterly inventory in 2024 Q2 was 5.32 Billion KRW , down -5.37% from previous quarter.
  • HLB Therapeutics Co.,Ltd. reported annual inventory of 6.45 Billion KRW in 2022, up 175.29% from previous year.
  • HLB Therapeutics Co.,Ltd. reported annual inventory of 2.34 Billion KRW in 2021, down -27.55% from previous year.
  • HLB Therapeutics Co.,Ltd. reported quarterly inventory of 5.62 Billion KRW for 2024 Q1, up 5.41% from previous quarter.
  • HLB Therapeutics Co.,Ltd. reported quarterly inventory of 5.86 Billion KRW for 2023 Q1, down -9.1% from previous quarter.

Annual Inventory Chart of HLB Therapeutics Co.,Ltd. (2023 - 2016)

Historical Annual Inventory of HLB Therapeutics Co.,Ltd. (2023 - 2016)

Year Inventory Inventory Growth
2023 5.33 Billion KRW -17.34%
2022 6.45 Billion KRW 175.29%
2021 2.34 Billion KRW -27.55%
2020 3.23 Billion KRW -2.24%
2019 3.31 Billion KRW -23.75%
2018 4.34 Billion KRW 136.83%
2017 1.83 Billion KRW 4.9%
2016 1.74 Billion KRW 0.0%

Peer Inventory Comparison of HLB Therapeutics Co.,Ltd.

Name Inventory Inventory Difference
HLB Co., Ltd. 11.42 Billion KRW 53.283%
iNtRON Biotechnology, Inc. 1.01 Billion KRW -427.722%
BINEX Co., Ltd. 28.26 Billion KRW 81.12%
Bioneer Corporation 41.35 Billion KRW 87.097%
Anterogen.Co.,Ltd. 1.91 Billion KRW -179.288%
MEDIPOST Co., Ltd. 14.51 Billion KRW 63.244%
CrystalGenomics, Inc. 1.55 Billion USD -243.185%
Helixmith Co., Ltd 914.11 Million KRW -483.715%
Chabiotech Co.,Ltd. 34.11 Billion KRW 84.36%
Medy-Tox Inc. 59.61 Billion KRW 91.05%
Peptron, Inc. 172.18 Million KRW -2998.844%
Amicogen, Inc. 46.83 Billion KRW 88.608%
Genexine, Inc. 3.8 Billion KRW -40.161%
LegoChem Biosciences, Inc. 196.83 Million KRW -2610.816%
ALTEOGEN Inc. 1.06 Billion KRW -399.44%
PharmaResearch Co., Ltd. 50.23 Billion KRW 89.378%
SillaJen, Inc. 1.21 Billion KRW -340.022%
JETEMA, Co., Ltd. 12.74 Billion KRW 58.121%
OliX Pharmaceuticals,Inc 468.4 Million KRW -1039.136%
Genomictree Inc. 496.53 Million KRW -974.618%
MedPacto, Inc. 620.00 KRW -860615714.032%
D&D Pharmatech 3.45 Billion KRW -54.652%
EASY BIO,Inc. 25.93 Billion KRW 79.429%
GI Innovation, Inc. - KRW -Infinity%